Cubist Systematic Strategies, LLC Surface Oncology, Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.42 - $3.15 $22,843 - $50,674	16,087 Added 144.3%	27,235 $45,000
Q1 2022 May 16, 2022	SELL	$2.65 - $5.08 $133,382 - $255,691	-50,333 Reduced 81.87%	11,148 $33,000
Q4 2021 Feb 14, 2022	BUY	$4.73 - $7.9 $290,805 - $485,699	61,481 New	61,481 $294,000
Q3 2021 Nov 15, 2021	SELL	$5.16 - $7.98 $342,624 - $529,872	-66,400 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.45 - $9.09 $626,649 - $883,138	-97,155 Reduced 59.4%	66,400 $495,000
Q1 2021 May 17, 2021	BUY	$7.25 - $13.82 $711,863 - $1.36 Million	98,188 Added 150.21%	163,555 $1.28 Million
Q4 2020 Feb 16, 2021	BUY	$6.87 - $10.48 $414,336 - $632,059	60,311 Added 1192.86%	65,367 $604,000
Q3 2020 Nov 16, 2020	BUY	$5.06 - $7.23 $25,583 - $36,554	5,056 New	5,056 $35,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.